KUALA LUMPUR, Malaysia, May 11 (IPS) – Thanks to President Biden, the US now supports a suspension of intellectual property (IP) rights to increase vaccine supplies. However, without vaccine developers sharing tacit technical knowledge for safe vaccine mass production, it will be difficult to rapidly scale up vaccine output.
Read the full story, “US Support for Vaccine Waiver Welcome, but More Needed”, on globalissues.org →
Coordinated action on clean air and climate change can net $15 for every dollar spent 
Human rights chief Türk renews call for end to spiralling Sudan war 
AI: Türk urges action before it becomes an ‘existential risk to humanity’ 
UNGA 81: A United Nations at a Turning Point 
LIECHTENSTEIN: ‘We Have One of the Strictest Abortion Bans in Europe’ 
Nuclear Victims’ Experiences Must Be at the Heart of Global Efforts for Assistance and Remediation